Search research articles
Contact Us
Filters
Showing results (31-40 of 133) with videos related to
Page
of 14
Sort By:
The Journal of Infectious Diseases
|
August 1, 1997
Improvement of inactivated influenza virus vaccines
R B Couch, W A Keitel, T R Cate
American Journal of Epidemiology
|
September 1, 1974
An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness
S B Greenberg, R B Couch, J A Kasel
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
July 1, 1974
Persistence of antibody to envelope antigens of Heq2Neq2 virus in ponies after infection and vaccination
T P Cameron, J A Kasel, R B Couch
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1971
Antigenicity of alum and aqueous adenovirus hexon antigen vaccines in man
J A Kasel, R B Couch, R G Douglas
Journal of Clinical Microbiology
|
September 1, 1993
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children
E A Dominguez, L H Taber, R B Couch
American Journal of Epidemiology
|
October 1, 1982
The influenza herald wave
W P Glezen, R B Couch, H R Six
Viral Immunology
|
January 1, 1993
Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons
I N Mbawuike, A R Lange, R B Couch
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
September 1, 1976
Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon
M W Harmon, S B Greenberg, R B Couch
American Journal of Epidemiology
|
February 1, 1988
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine
W A Keitel, T R Cate, R B Couch
The Journal of Infectious Diseases
|
May 1, 1987
Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology
J M Zahradnik, R B Couch, J L Gerin
Page
of 14
Search research articles
Search
Showing results (31-40 of 133) with videos related to
Sort By:
Page
of 14
The Journal of Infectious Diseases
|
August 1, 1997
Improvement of inactivated influenza virus vaccines
R B Couch, W A Keitel, T R Cate
American Journal of Epidemiology
|
September 1, 1974
An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness
S B Greenberg, R B Couch, J A Kasel
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
July 1, 1974
Persistence of antibody to envelope antigens of Heq2Neq2 virus in ponies after infection and vaccination
T P Cameron, J A Kasel, R B Couch
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1971
Antigenicity of alum and aqueous adenovirus hexon antigen vaccines in man
J A Kasel, R B Couch, R G Douglas
Journal of Clinical Microbiology
|
September 1, 1993
Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children
E A Dominguez, L H Taber, R B Couch
American Journal of Epidemiology
|
October 1, 1982
The influenza herald wave
W P Glezen, R B Couch, H R Six
Viral Immunology
|
January 1, 1993
Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons
I N Mbawuike, A R Lange, R B Couch
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
September 1, 1976
Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon
M W Harmon, S B Greenberg, R B Couch
American Journal of Epidemiology
|
February 1, 1988
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine
W A Keitel, T R Cate, R B Couch
The Journal of Infectious Diseases
|
May 1, 1987
Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology
J M Zahradnik, R B Couch, J L Gerin
Page
of 14